Louise van der Weyden and Bushra Abu‐Helil argue that cross‐species medicines licensing should form part of the once‐in‐a‐generation veterinary reform.
No takes yet. Share an insight, caveat, or question.
Weyden et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: